Skip to main content

Trusted Solutions for Nucleic Acid Therapeutics

Partner with Agilent’s Nucleic Acid Solutions Division and benefit from industry leading experience to efficiently advance your lead oligo candidates from clinic to market with a common goal of patient health and safety.

Collaboration is important to a successful strategy. Many biotech and pharma companies increase their chances of success by partnering with an experienced development partner, like Agilent, who can help them make decisions, solve technical problems and save money at critical points along the way. Discover how Agilent can help you

Oligonucleotide API Manufacturing

Agilent’s Nucleic Acid Solutions Division, an FDA Inspected Facility